**What is already known**

Brain computed tomography (CT) is a primary diagnostic approach in patients with acute altered mental status. However, recent studies revealed high rates of negative brain CT findings and issues associated with unnecessary radiation exposure.

**What is new in the current study**

Considering the neurologic examination findings (presence of focal neurologic deficit and Glasgow Coma Scale) and C-reactive protein results, unnecessary use of brain CT can be reduced.

INTRODUCTION
============

Altered mental status (AMS) is one of the most common chief complaints reported in 4% to 10% of emergency department (ED) patients \[[@b1-ceem-16-163]-[@b3-ceem-16-163]\]. A wide range of clinical conditions can cause acute AMS, either direct central nervous system (CNS) pathologies such as stroke, seizure, and encephalitis or non-CNS-origin such as sepsis, metabolic imbalance, cardiogenic shock, and intoxication. Moreover, history taking in patients with AMS is, due to their condition, problematic. Thus, determining the exact etiology in patients with AMS is challenging for emergency physicians \[[@b1-ceem-16-163],[@b3-ceem-16-163]\].

Brain computed tomography (CT), the primary diagnostic tool to identify intracranial pathologies, has been recommended for AMS \[[@b1-ceem-16-163],[@b3-ceem-16-163],[@b4-ceem-16-163]\]. Unfortunately, brain CT has some limitations when used to diagnose non-intracranial pathology-related AMS \[[@b2-ceem-16-163],[@b5-ceem-16-163],[@b6-ceem-16-163]\].

Studies evaluating the brain CT of patients with AMS without trauma were limited, as most previous studies investigated its effectiveness in patients with traumatic brain injuries. Therefore, this study aimed to evaluate the effectiveness of brain CT in patients with non-traumatic AMS and, consequently, determine the clinical characteristics predictive of positive brain CT findings in these patients.

METHODS
=======

Study setting
-------------

This study was conducted at a single urban academic hospital with an annual ED census of 55,000. A retrospective ED-based registry of AMS was reviewed from April to December 2014. Nontrauma patients who had Glasgow Coma Scale (GCS) scores of ≤14 and presented to the ED with noncommunicable disease were enrolled in this study. Those who had previous neurologic deficit (modified Rankin Scale of ≥2), uncomplicated ethanol ingestion, cardiac arrest, aged \<18 years, or recovered from mental illness at the time of the initial ED evaluation were excluded.

Basic patient characteristics such as age, sex, medical history and previous medications, initial vital signs, neurologic findings, initial laboratory test results, brain CT findings, and final diagnoses were collected. One senior resident (third or fourth year) or faculty of emergency medicine performed full neurologic exams in the patients to determine any cranial nerve abnormality, motor weakness, or cerebellar dysfunction. Only brain CT results conducted in the ED were included for evaluation. Brain CT findings, formal reports, and final diagnoses were reviewed by a faculty of emergency medicine. "Positive CT finding" was defined as the presence of abnormal findings suggestive of acute AMS. This study was approved by the institutional review board of the study hospital (16-2015-3), and written informed consents were waived.

Statistical analysis
--------------------

Statistical analyses were performed using the IBM SPSS Statistics ver. 20 (IBM Corp., Armonk, NY, USA) and R ver. 3.3.1 (R Foundation for Statistical Computing, Vienna, Austria). Categorical variables were recorded as frequency with the corresponding percentage and compared using the chi-square or Fisher's exact test as appropriate. Continuous variables were expressed as the mean± standard deviation, and Student t-tests were performed. Multivariate logistic models were performed using the forward selection approach, and the results were recorded as adjusted odds ratio (OR) with 95% confidence interval (CI). Conditional Inference Tree Analysis was performed to generate a decision tree to predict positive brain CT results using the R package "Party" ver. 1.0-25 \[[@b7-ceem-16-163],[@b8-ceem-16-163]\]. All statistical tests were two-tailed at 0.05 level of significance.

RESULTS
=======

A total of 508 patients treated during the study period met the eligibility criteria and were enrolled in the registry. Among them, 367 (72.2%) patients had undergone brain CT in the ED. All patients with a focal neurologic deficit underwent brain CT, except one who underwent brain magnetic resonance imaging. [Table 1](#t1-ceem-16-163){ref-type="table"} presents the baseline characteristics of the patients.

A total of 146 patients had positive CT findings: 81 (55.5%) had intracranial hemorrhage, 54 (37.0%) infarction, 10 (6.8%) tumor, and 1 (0.7%) brain swelling. The most common cause was cerebrovascular etiology (122, 83.6%) ([Table 2](#t2-ceem-16-163){ref-type="table"}). [Table 3](#t3-ceem-16-163){ref-type="table"} shows the clinical parameters according to brain CT results.

In the multivariate analysis, the presence of focal neurologic deficit (OR, 132.6; 95% CI, 37.8 to 464.6), C-reactive protein (CRP) of \<2 mg/dL (OR, 3.9; 95% CI, 1.4 to 10.6), and GCS score of \<9 (OR, 2.4; 95% CI, 1.2 to 4.8) were significantly associated with positive brain CT results ([Table 4](#t4-ceem-16-163){ref-type="table"}).

To generate the decision tree in the Conditional Inference Tree Analysis, the presence of focal neurologic deficit was the primary predictive factor (96.7%) of positive CT result. In patients without focal neurologic deficit, 39 (37.5%) with positive CT scans had GCS scores of \<9 and CRP levels of \<2 mg/dL. Sixteen patients (11.7%) showed GCS scores of ≥9, and 4 (11.1%) had GCS scores of \<9 and CRP levels of ≥2 mg/dL. The accuracy of the decision tree was 0.8311 (95% CI, 0.7887 to 0.868; P\<0.001) ([Fig. 1](#f1-ceem-16-163){ref-type="fig"}).

DISCUSSION
==========

Acute AMS caused by intracranial pathology usually requires immediate diagnosis and intervention. Brain CT is regarded as one of the essential approaches to manage AMS \[[@b4-ceem-16-163]\]. With technical advancements over the past decade, utilization of brain CT in the ED has continuously increased \[[@b9-ceem-16-163]\]. However, increased rates of CT use can expose patients to excessive levels of radiation and society to higher medical costs. One retrospective study that reviewed brain CT utilization in a single ED found that the rate of brain CT use had increased by 60% over a 7-year period; however, the diagnostic yield for intracranial hemorrhage had remained constant at approximately 3% \[[@b10-ceem-16-163]\].

Therefore, several guidelines for brain CT have been developed, but are mostly relevant to traumatic brain injuries \[[@b11-ceem-16-163]-[@b13-ceem-16-163]\]. Moreover, studies on patients with AMS using brain CT were limited. Hardy and Brennan \[[@b2-ceem-16-163]\] evaluated the brain CT of elderly patients (aged \>70 years) with acute confusion, noting that positive findings were detected in only 14%. Partel et al. \[[@b6-ceem-16-163]\] evaluated the brain CT data of poisoned patients with AMS, determining that no cases had abnormal CT findings and that brain CT was performed at a higher rate for these patients nonetheless.

Leong et al. \[[@b5-ceem-16-163]\] evaluated 382 brain CT scans performed on patients with AMS over the course of 11 months at a single ED. They reported that diastolic blood pressure of \>80 mmHg, GCS score of \<15, focal weakness, increasing plantar response, dilated pupils, and use of antiplatelet and anticoagulant medications were factors associated with abnormal CT findings. In the present study, the following patient characteristics differed: first, the GCS scores in all patients were \<15, and second, trauma patients were excluded. Furthermore, we evaluated laboratory test results that are crucially important for differential diagnosis in the ED, which were not included by Leong et al. \[[@b5-ceem-16-163]\].

In our analysis, the presence of focal neurologic deficit was a significant factor suggesting positive brain CT findings ([Table 4](#t4-ceem-16-163){ref-type="table"} and [Fig. 1](#f1-ceem-16-163){ref-type="fig"}). Only three (3.3%) patients with focal neurologic deficit had negative CT findings: two had an acute ischemic lesion on brain magnetic resonance imaging and one hypotension-caused AMS. Only one patient had cerebellar dysfunction, who needed a cerebellar function test requiring cooperation that is typically not possible in patients with AMS, which might affect the results. Furthermore, changes in the mental status are relatively infrequent in patients with posterior circulation stroke \[[@b14-ceem-16-163]\].

Based on our results, initial GCS scores of \<9 and CRP levels of \<2 mg/dL were also correlated with positive brain CT findings ([Table 4](#t4-ceem-16-163){ref-type="table"} and [Fig. 1](#f1-ceem-16-163){ref-type="fig"}). Traditionally, brain imaging studies have been recommended for patients with low GCS scores, a protocol supported by our results \[[@b4-ceem-16-163],[@b11-ceem-16-163],[@b15-ceem-16-163]\]. Neurologic evaluation findings in patients with lower GCS scores (\<9) might be more limited and less accurate than those in patients with higher GCS scores, simply due to poor cooperation \[[@b3-ceem-16-163]\]. Neurologic evaluation may be easier and more accurate in patients with higher GCS scores.

CRP is a pentraxin released by the liver during the phase response of acute inflammatory reaction. Although every inflammatory condition can increase the CRP level, its high elevation is thought to be suggestive of infection. Patients with severe sepsis and septic shock had higher CRP levels than those with noninfectious systemic inflammatory response syndrome \[[@b16-ceem-16-163]\]. In our study, lower CRP levels (\<2 mg/dL) were associated with positive CT results ([Table 3](#t3-ceem-16-163){ref-type="table"} and [Fig. 1](#f1-ceem-16-163){ref-type="fig"}). Most patients with positive CT results (93.2%) have CNS pathology (cerebrovascular, CNS infection, CNS tumor, seizure/postictal confusion, and other CNS pathologies) ([Table 2](#t2-ceem-16-163){ref-type="table"}). CRP level can be also elevated in many CNS pathologies, such as ischemic stroke and brain hemorrhage. However, in these conditions, increased CRP levels occur several hours after the brain injury; therefore, routine evaluation of CPR levels is not recommended as an initial assessment, and these can affect our results \[[@b17-ceem-16-163],[@b18-ceem-16-163]\].

Based on the Conditional Inference Tree Analysis results, we suggest the following protocol: if the patient has focal neurologic deficit, brain CT should be performed (CT positivity rate, 96.7%); if the patient has no focal neurologic deficit and if the initial GCS score is \<9 and CRP is \<2 mg/dL, brain CT can be helpful (CT positivity rate, 37.5%); and if GCS score is ≥9 or \<9 and CRP ≥2 mg/dL, brain CT might not be helpful (CT positivity rate, 11.7% and 11.1%, respectively) ([Fig. 1](#f1-ceem-16-163){ref-type="fig"}). For the generalization of these results, an external validation study should be conducted.

More than 70% of patients included in the present study underwent brain CT, which is higher compared to relevant previous reports. This could have been influenced by the facts that cases of alcohol ingestion or of AMS in previously neurologically impaired patients were excluded from our study. The rate of positive findings on brain CT was 39.8%, which is not much lower than that of the previous studies (14%, 45%) \[[@b2-ceem-16-163],[@b5-ceem-16-163]\]. Regional and cultural factors, which should be noted here, can also affect the pattern of brain CT utilization.

The present study has several limitations. First, its design is retrospective. Patients without brain CT were excluded from the analysis, although if they had been included and had undergone brain CT, abnormal lesions might have also been found, which could have affected the results. The neurologic status of these patients changes easily, even in those with only minor medical conditions \[[@b1-ceem-16-163],[@b3-ceem-16-163]\]. Moreover, in the retrospective setting, degrees of AMS are often difficult to understand, and, therefore, evaluate. Finally, the study lacks an ordering protocol for brain CT; instead, CT scans were conducted based on the attending physician's decision, which could have resulted in a selection bias. Large-scale prospective multicenter studies will overcome these limitations.

In conclusion, positive findings were detected in 39.8% of patients with acute AMS who underwent brain CT in the ED. Initial GCS scores of \<9, CRP levels of \<2 mg/dL, and presence of focal neurologic deficit were significantly associated with positive brain CT findings.
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![Conditional inference tree for positive computed tomography (CT) findings. A total of 90 patients had focal neurologic deficit, among whom 87 (96.7%) had positive CT findings (node 2). One hundred and four patients had Glasgow Coma Scale (GCS) scores of \<9 and C-reactive protein (CRP) levels of \<2 mg/dL; among them, 39 (37.5%) had positive CT findings (node 7). One hundred and thirty-seven patients had GCS scores of ≥9; among them, 16 (11.7%) had positive CT findings (node 4). Among the 36 patients with GCS scores of \<9 and CRP levels of ≥2 mg/dL, 4 (11.1%) had positive CT findings (node 6).](ceem-16-163f1){#f1-ceem-16-163}

###### 

Clinical characteristics of patients with acute mental changes

  Characteristics                                                           Brain CT          P-value           
  ------------------------------------------------------------------------- ----------------- ----------------- ----------
  Age (yr)                                                                  66.32 ± 15.27     63.27 ± 18.21     0.079
  Male                                                                      195 (52.0)        66 (46.8)         
  Current-smoker                                                            71 (19.3)         17 (16.3)         0.317
  Frequent alcohol drinking^[a)](#tfn1-ceem-16-163){ref-type="table-fn"}^   35 (9.5)          8 (8.2)           0.273
  Glasgow Coma Scale                                                        8.45 ± 3.37       9.47 ± 3.50       0.002
  Mental status                                                                                                 0.006
   Confusion                                                                0 (0)             1 (0.7)           
   Lethargy                                                                 223 (60.8)        104 (73.8)        
   Stupor                                                                   66 (18.0)         15 (10.6)         
   Semicoma                                                                 42 (11.4)         6 (4.3)           
   Coma                                                                     36 (9.8)          15 (10.6)         
  Underlying conditions                                                                                         
   Hypertension                                                             166 (45.2)        64 (45.4)         0.981
   Diabetes mellitus                                                        110 (30.0)        59 (41.8)         0.015
   Malignancy                                                               45 (12.3)         22 (15.6)         0.342
   Chronic liver disease                                                    35 (9.5)          15 (10.6)         0.709
   Chronic kidney disease                                                   26 (7.1)          13 (9.2)          0.418
   Cerebrovascular disease                                                  92 (25.1)         23 (16.3)         0.029
   Parkinson's disease                                                      8 (2.2)           4 (2.8)           0.746
   Dementia                                                                 42 (11.4)         16 (11.3)         \> 0.990
  Medication                                                                                                    
   Psychotropic                                                             39 (10.6)         24 (17.0)         0.050
   Anticonvulsant                                                           21 (5.7)          12 (8.51)         0.270
   Cardiovascular                                                           177 (48.2)        68 (48.2)         0.861
   Opioid                                                                   6 (1.6)           5 (3.5)           0.192
   Medications for chronic neurologic disorder                              25 (6.8)          9 (6.8)           0.892
  Initial vital signs                                                                                           
   SBP (mmHg)                                                               111.67 ± 63.78    93.72 ± 61.37     0.004
   DBP (mmHg)                                                               62.90 ± 34.76     54.67 ± 3.95      0.016
   Heart rate (/min)                                                        88.58 ± 23.97     91.96 ± 22.14     0.214
   Respiratory rate (/min)                                                  16.68 ± 8.39      15.66 ± 10.37     0.299
   Body temperature (°C)                                                    36.55 ± 1.03      36.51 ± 1.04      0.106
  Laboratory results                                                                                            
   WBC (10^3^/μL)                                                           11.34 ± 8.43      11.79 ± 10.34     0.707
   Hemoglobin (g/dL)                                                        12.76 ± 2.62      12.23 ± 2.73      0.045
   Sodium (mM/L)                                                            137.3 ± 6.18      135.9 ± 7.43      0.031
   Potassium (mM/L)                                                         4.10 ± 0.84       4.25 ± 1.09       0.150
   BUN (mg/dL)                                                              25.96 ± 21.26     26.97 ± 20.46     0.629
   Creatinine (mg/dL)                                                       1.82 ± 7.65       1.58 ± 1.65       0.717
   Glucose (mg/dL)                                                          174.74 ± 127.03   170.97 ± 151.20   0.778
   AST (IU/L)                                                               67.82 ± 170.79    82.89 ± 269.83    0.454
   ALT (IU/L)                                                               31.55 ± 71.73     36.05 ± 79.17     0.539
   Total bilirubin (mg/dL)                                                  1.48 ± 2.24       1.54 ± 2.39       0.781
   Albumin (g/dL)                                                           3.83 ± 2.13       3.60 ± 0.63       0.212
   Creatine kinase (U/L)                                                    353.02 ± 772.33   347.09 ± 704.58   0.945
   C-reactive protein (mg/dL)                                               3.21 ± 6.86       4.55 ± 8.53       0.098
  Neurologic exam                                                                                               
   Focal neurologic deficit^[b)](#tfn2-ceem-16-163){ref-type="table-fn"}^   90 (26.3)         1 (0.7)           \< 0.001
   Cranial nerve abnormality                                                49 (13.4)         1 (0.7)           \< 0.001
   Extremity abnormality                                                    78 (21.3)         1 (0.7)           \< 0.001
   Cerebellar abnormality                                                   1 (0.3)           0 (0)             \> 0.990

Values are presented as mean±standard deviation or number (%).

CT, computed tomography; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; BUN, blood urea nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase.

\>4 days per week.

Cranial nerve, extremity, and cerebellar abnormality.

###### 

Etiologies of acute altered mental status in each group

  Etiology                      CT negative   CT positive
  ----------------------------- ------------- -------------
  Cerebrovascular               5 (2.3)       122 (83.6)
  CNS infection                 4 (1.8)       2 (1.4)
  CNS tumor                     1 (0.5)       5 (3.4)
  Seizure/postictal confusion   29 (13.1)     6 (4.1)
  Other CNS pathology           4 (1.8)       1 (0.7)
  Sepsis                        27 (12.2)     5 (3.4)
  Hepatic encephalopathy        24 (10.9)     1 (0.7)
  Hypoglycemia                  18 (8.1)      0 (0)
  Other metabolic derangement   32 (14.5)     2 (1.4)
  Cardiovascular                10 (4.5)      0 (0)
  Hypoxia                       6 (2.7)       1 (0.7)
  Drug intoxication             43 (19.5)     1 (0.7)
  Psychiatric                   6 (2.7)       0 (0)
  Environmental injury          10 (4.5)      0 (0)
  Unknown                       2 (0.9)       0 (0)

Values are presented as number (%).

CT, computed tomography; CNS, central nervous system.

###### 

Clinical characteristics and univariate analysis according to the result of brain CT

  Characteristics                                                           CT findings       P-value           
  ------------------------------------------------------------------------- ----------------- ----------------- ----------
  Age (yr)                                                                  65.93 ± 15.48     66.58 ± 15.16     0.689
  Male                                                                      79 (54.1)         116 (52.5)        0.761
  Current-smoker                                                            30 (20.5)         41 (18.6)         
  Frequent alcohol drinking^[a)](#tfn3-ceem-16-163){ref-type="table-fn"}^   18 (12.3)         17 (7.7)          0.198
  GCS                                                                       7.82 ± 3.31       8.86 ± 3.17       0.003
  Initial GCS \< 9                                                          84 (57.5)         99 (44.8)         0.017
  Mental status                                                                                                 0.032
   Confusion                                                                0 (0)             0 (0)             
   Lethargy                                                                 77 (52.8)         146 (66.1)        
   Stupor                                                                   30 (20.5)         36 (16.3)         
   Semicoma                                                                 18 (12.3)         24 (10.9)         
   Coma                                                                     21 (14.4)         15 (6.8)          
  Underlying conditions                                                                                         
   Hypertension                                                             66 (45.2)         100 (45.2)        0.924
   Diabetes mellitus                                                        30 (20.5)         80 (36.1)         0.002
   Malignancy                                                               15 (10.3)         30 (13.6)         0.002
   Chronic liver disease                                                    6 (4.1)           29 (13.1)         0.004
   Chronic kidney disease                                                   5 (3.4)           21 (9.5)          0.029
   Cerebrovascular disease                                                  43 (29.5)         49 (22.2)         0.096
   Parkinson's disease                                                      1 (0.7)           7 (3.2)           0.115
   Dementia                                                                 8 (5.5)           34 (15.4)         0.004
  Medication                                                                                                    
   Psychotropic                                                             7 (4.8)           32 (14.5)         0.004
   Anticonvulsant                                                           5 (3.4)           16 (7.2)          0.136
   Cardiovascular                                                           71 (48.6)         106 (48.0)        0.699
   Opioid                                                                   2 (1.4)           4 (1.8)           0.766
   Medications for chronic neurologic disorder                              6 (4.1)           19 (8.6)          0.104
  Initial vital sign                                                                                            
   SBP (mmHg)                                                               117.02 ± 70.20    108.14 ± 59.06    0.208
   DBP (mmHg)                                                               64.90 ± 37.74     61.58 ± 32.66     0.385
   Heart rate (/min)                                                        83.40 ± 23.00     91.83 ± 24.04     0.003
   Respiratory rate (/min)                                                  16.03 ± 8.56      17.10 ± 8.27      0.235
   Body temperature (°C)                                                    36.40 ± 0.83      36.64 ± 1.13      0.060
  Lab results                                                                                                   
   WBC (10^3^/μL)                                                           11.90 ± 8.82      10.96 ± 8.17      0.337
   Hemoglobin (g/dL)                                                        13.30 ± 2.48      12.41 ± 2.66      0.607
   Sodium (mM/L)                                                            137.78 ± 4.38     136.9 ± 7.12      0.187
   Potassium (mM/L)                                                         3.90 ± 0.71       4.24 ± 0.78       \< 0.001
   BUN (mg/dL)                                                              22.78 ± 18.84     28.07 ± 22.51     0.020
   Creatinine (mg/dL)                                                       1.24 ± 1.43       2.19 ± 9.78       0.248
   Glucose (mg/dL)                                                          169.29 ± 56.11    178.35 ± 157.39   0.434
   AST (IU/L)                                                               44.62 ± 51.64     83.14 ± 214.88    0.011
   ALT (IU/L)                                                               25.09 ± 45.21     35.77 ± 84.57     0.118
   Total bilirubin (mg/dL)                                                  1.23 ± 1.00       1.64 ± 2.76       0.047
   Albumin (g/dL)                                                           4.14 ± 3.28       3.62 ± 0.62       0.021
   Creatine kinase (U/L)                                                    296.61 ± 599.37   389.28 ± 865.01   0.294
   CRP (mg/dL)                                                              1.40 ± 3.41       4.41 ± 8.17       \< 0.001
   C-reactive protein \< 2 mg/dL                                            125 (85.6)        151 (68.3)        \< 0.001
  Neurologic exam                                                                                               
   Focal neurologic deficit                                                 87 (59.6)         3 (1.4)           \< 0.001
   Cranial nerve abnormality                                                47 (32.2)         2 (0.9)           \< 0.001
   Extremity abnormality                                                    76 (52.1)         2 (0.9)           \< 0.001
   Cerebellar abnormality                                                   1 (0.7)           0 (0)             0.398

Values are presented as mean±standard deviation or number (%).

CT, computed tomography; GCS, Glasgow Coma Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; BUN, blood urea nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase.

\>4 days per week.

###### 

Multivariate analysis results

  Variable                   Adjusted odds ratio   95% Confidence interval   P-value
  -------------------------- --------------------- ------------------------- ----------
  Focal neurologic deficit   132.6                 37.8--464.6               \< 0.001
  Glasgow Coma Scale \< 9    2.4                   1.2--4.8                  0.016
  C-reactive protein \< 2    3.9                   1.4--10.6                 0.008
